| Original language | English |
|---|---|
| Pages (from-to) | 588-589 |
| Number of pages | 2 |
| Journal | JAMA - Journal of the American Medical Association |
| Volume | 325 |
| Issue number | 6 |
| DOIs |
|
| Publication status | Published - 9 Feb 2021 |
Bibliographical note
Funding Information:Author Affiliations: Berkeley Institute for Data Science, University of California, Berkeley, San Francisco (Eaneff); School of Public Health, University of California, Berkeley (Obermeyer); Bakar Computational Health Sciences Institute, University of California, San Francisco (Butte). Corresponding Author: Atul J. Butte, MD, PhD, UCSF Valley Tower, PO Box 0110, Room 22J, 490 Illinois St, San Francisco, CA 94107 ([email protected]). Conflict of Interest Disclosures: Ms Eaneff reported being supported by the Innovate for Health Data Science Health Innovation program, including support from the UCSF Bakar Computational Health Sciences Institute, the UC Berkeley Institute for Data Science, and Johnson & Johnson. Dr Obermeyer reported receiving equity from Berkeley Data Ventures and LookDeep Health. Dr Butte reported receiving grants from Janssen during the conduct of the study; receiving personal fees from and being a shareholder in Personalis and NuMedii; receiving personal fees from Samsung, Mango Tree Corporation, 10x Genomics, Helix, Pathway Genomics, Verinata, Geisinger Health, Regenstrief Institute, Gerson Lehman Group, Roche, Merck, Genentech, Novartis, Covance, and AlphaSights; being a minor shareholder in Sutro, Vet24seven, Assay Depot, Nuna Health, Snap, Illumina, CVS, Biogen, Amazon, 10x Genomics, Sarepta, Microsoft, Google, Facebook, Regeneron, Moderna, and Sanofi; receiving honoraria and travel reimbursement for invited talks from Genentech, Takeda, Varian, Roche, Pfizer, Merck, Lilly, Mars, Siemens, Optum, Abbott, Celgene, AstraZeneca, AbbVie, Johnson & Johnson, Westat, and academic institutions, state or national agencies, medical or disease-specific foundations and associations, and health systems; receiving royalty payments through Stanford University for patents and other disclosures licensed to NuMedii and Personalis; and having research funded by the National Institutes of Health, Robert Wood Johnson Foundation, Northrup Grumman, Genentech, Johnson & Johnson, the US Food and Drug Administration, the Leon Lowenstein Foundation, the Intervalien Foundation, Priscilla Chan and Mark Zuckerberg, the Barbara and Gerson Bakar Foundation, the March of Dimes, Juvenile Diabetes Research Foundation, California Governor’s Office of Planning and Research, California Institute for Regenerative Medicine, L’Oreal, and Progenity.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.